The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen-Resistant Breast Cancer Cells In Vitro

Figure 2

Chemical structure of canertinib (EGFR-irreversible tyrosine kinase inhibitor).